Clinical Trials Directory

Trials / Completed

CompletedNCT01728610

Effect of Probiotic Supplement in Alleviating Functional Gastrointestinal Symptoms

Effect of Probiotic Supplement in Alleviating Functional Gastrointestinal Symptoms (IBS-2)

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
391 (actual)
Sponsor
Danisco · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to analyse the effect of a probiotic supplement on functional intestinal symptoms among subjects diagnosed with irritable bowel syndrome (IBS).

Detailed description

The aim of the intervention is to analyse the effect of a probiotic supplement in a dose-responsive set up on functional intestinal symptoms among subjects diagnosed with IBS according to Rome III criteria. Subjective assessment of bowel symptoms, quality of life, anxiety and depression and adequate relief will be assessed as with questionnaires as outcome measures. The intestinal microbiota will be analysed from faecal samples.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbiotic (Active high)Higher dose of probiotic supplement
DIETARY_SUPPLEMENTProbiotic (Active low)Lower dose of probiotic supplement
DIETARY_SUPPLEMENTPlaceboPlacebo

Timeline

Start date
2012-10-01
Primary completion
2014-11-01
Completion
2014-11-01
First posted
2012-11-20
Last updated
2016-01-26

Locations

2 sites across 1 country: Finland

Source: ClinicalTrials.gov record NCT01728610. Inclusion in this directory is not an endorsement.